Internal Medicine Alert – April 30, 2011
April 30, 2011
View Issues
-
You're Overweight — There, I've Said It
People who are told by their physicians that they are overweight or obese are more likely to identify themselves as such, more likely to want to lose weight, and more likely to try. -
STD Management — What's New?
The 2006 Centers for Disease Control and Prevention (CDC) sexually transmitted disease (STD) guidelines have been updated. -
Stopping Aspirin May Increase Stroke Risk
The health improvement network UK primary care database was queried for all patients aged 50-84 who were prescribed low-dose aspirin (75-300 mg/day) for the secondary prevention of cardiovascular disease in 2000-2007. -
Roflumilast Tablets (Daliresp®)
An oral selective phosphodiesterase 4 (pde4) inhibi-tor has been approved for the treatment of patients with chronic obstructive pulmonary disease (COPD). Roflumilast is the first drug of this type to be approved for this indication. It is marketed by Forest Pharmaceuticals as Daliresp. -
Clinical Briefs by Louis Kuritzky, MD
In the general population, there is a linear and reversible relationship between salt intake and blood pressure (BP): more salt in begets higher BP, and salt restriction lowers BP.